World Pharma Newsfeed
European Commission Issues Positive Decision for Approval of Seroquel XR
AstraZeneca announced that the European Commission (EC) has issued a positive decision for the approval of once-daily SE...
Pfizer to Acquire FoldRx Pharmaceuticals
Pfizer Inc. (NYSE: PFE) and FoldRx Pharmaceuticals, Inc., a privately held drug discovery and clinical development compa...
Starting signal sounded: analytica 2012 to offer Early Bird discount
The starting signal has sounded for analytica 2012 in Munich. Application forms for the 23rd International Trade Fair fo...
Global market launch of Daxas® (Roflumilast) kicks off in Germany
Stefan Brinkmann, Managing Director of Nycomed GmbH, kicked off the German market launch of Daxas® (Roflumilast) in Oran...
Bayer's Rivaroxaban Successfully Meets Primary Efficacy Outcome
The Phase III EINSTEIN-DVT clinical trial of the oral anticoagulant rivaroxaban demonstrated non-inferiority compared to...
Shire Announces Support for Inflammatory Bowel Disease (IBD) Fellowships
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced its support for inflammat...
European Medicines Agency starts review of Pandemrix
The European Medicines Agency has launched a review of Pandemrix on the request of the European Commission to investigat...
Genzyme Confirms Receipt of Unsolicited Proposal
Genzyme Corp. (NASDAQ: GENZ) today confirmed that it has received an unsolicited, non-binding proposal from Sanofi-Avent...
Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that it has submitted a non-binding proposal to acquire Genzyme (...
Genetic substudy shows fewer major cardiovascular events with ticagrelor (BRILINTA)
A new genetic substudy of PLATO (A Study of PLATelet Inhibition and Patient Outcomes) showed that the effects on a combi...
